Qube Research & Technologies LTD Amicus Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,466,911 shares of FOLD stock, worth $31.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,466,911

Previous 1,070,501 223.86%

Holding current value

$31.2 Million

Previous $8.74 Million 127.42%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.64 - $8.0 $13.5 Million - $19.2 Million	2,396,410 Added 223.86%	3,466,911 $19.9 Million
Q1 2025 May 15, 2025	BUY	$8.16 - $9.85 $2.18 Million - $2.63 Million	267,423 Added 33.3%	1,070,501 $8.74 Million
Q4 2024 Feb 14, 2025	BUY	$9.36 - $12.01 $1.05 Million - $1.35 Million	112,160 Added 16.23%	803,078 $7.56 Million
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $6.02 Million - $7.62 Million	629,928 Added 1032.84%	690,918 $7.38 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $4.48 Million - $5.82 Million	-495,373 Reduced 89.04%	60,990 $605,000
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $6.36 Million - $7.92 Million	556,363 New	556,363 $6.55 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $1.53 Million - $1.89 Million	139,829 Added 217.5%	204,119 $2.26 Million
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $57,154 - $73,393	-5,779 Reduced 8.25%	64,290 $784,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $688,077 - $893,379	70,069 New	70,069 $732,000
Q4 2021 Feb 01, 2022	SELL	$9.82 - $12.44 $349,277 - $442,465	-35,568 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.74 - $11.84 $184,580 - $250,048	21,119 Added 146.16%	35,568 $340,000
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $101,819 - $125,316	-11,690 Reduced 44.72%	14,449 $139,000
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $240,478 - $623,676	26,139 New	26,139 $258,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $412,963 - $763,077	-30,658 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $262,234 - $323,266	20,344 Added 197.25%	30,658 $433,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $91,382 - $161,826	10,314 New	10,314 $156,000

Others Institutions Holding FOLD

# of Institutions

307

Shares Held

332M

Call Options Held

396K

Put Options Held

249K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.52B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Amicus Therapeutics, Inc. Transaction History